Organon

For Lauren Gencarelli, her commitment to Organon’s mission is fueled by her personal experience as a mother of a child who was diagnosed with eczema when he was just a few months old. From understanding flare-up triggers to navigating treatment options, her and her son’s journey has gone from struggle to strength. Read more about their story and how she’s continuing to advocate for others facing similar challenges: https://ogn.llc/6040qSQze

Our next feature in “Minds Behind the Science” spotlights Allison Armstrong, PhD, an Asset Development Team Leader at Organon who oversees the strategic development of new therapies. From early inspirations in science and rare diseases to driving real-world change in women’s health, Allison’s work is centered around empathy, passion, and innovation. Her journey from drug discovery to clinical development began with a pivotal moment early in her career when she attended a patient and family caregiver meeting for rare pediatric metabolic diseases. From that point, her work wasn’t just about the science; it was about the patients living with these diseases every day. Today, her team is working on a program that aims to bring more treatment options to women with polycystic ovary syndrome (PCOS)—a condition which affects an ‘estimated 8–13% of women of reproductive age, and up to 70% of affected women remain undiagnosed worldwide. “Everyone you talk to at Organon has this drive to improve the treatment options available for women’s health conditions,” Allison says. Learn more about how her teamwork-centered approach helps drive innovation at Organon, where the focus is always on delivering important therapies to patients around the world: https://ogn.llc/6045qqkfT #MindsBehindTheScience #WomenInScience #PolycysticOvarySyndrome #PCOS #WomensHealth

#NEWS: Organon announced today that it has acquired regulatory and commercial rights in the U.S. for a #biosimilar product that complements our existing business, expanding our immunology portfolio with a multi-indication #arthritis treatment. Read the news: https://ogn.llc/6045qUBG5 #rheumatology #rheumatologist

Today, we announced with Shanghai Henlius Biotech that the European Medicines Agency has validated the Marketing Authorization Application for an investigational #biosimilar. Read the #news: https://ogn.llc/6049qYBkT

Beyond inadequate access to reproductive healthcare, outside influences, stigma, and misinformation can shape a woman’s understanding of her sexual and reproductive health. Our team visited select community health clinics in contraceptive deserts to understand these influences and see how each clinic is working to expand health education. #HerPlanHerPower #WomensHealth #ReproductiveHealth

Endometriosis affects about 10% of reproductive-age women globally, but it’s often misdiagnosed and misunderstood. This condition isn’t just about pain–it’s missed workdays, financial burdens, and the emotional effect of feeling unheard. As a company focused on addressing health conditions that are unique to women, affect her disproportionately or impact her differently, we’ll continue to bring awareness, investment, and scientific and commercial expertise to the healthcare ecosystem supporting the health of women. #WomensHealth #Endometriosis #EndometriosisActionMonth #EndometriosisAwareness

Research has shown that women are more likely to experience atypical heart attack symptoms, and younger women are more likely to be misdiagnosed by a doctor. Organon META (Middle East, Turkey & Africa)'s Mis(s)diagnosed campaign highlights these overlooked symptoms and the medical gender data gap. By educating and spreading awareness, we aim to help reduce misdiagnosis and improve heart health outcomes. Watch our video to learn more. Together, Organon is committed to advancing the health of women everywhere and creating a brighter future for her.❤️ #HeartHealth #WomensHealth #CardiovascularDisease

Caring for a child with eczema can have its fair share of challenges. Watch as Jaylin shares her journey in navigating her daughter’s eczema diagnosis and how finding education, support, and community helped them both thrive. #EczemaAwareness #Eczema #Dermatology

Board-certified OB/GYN, Dr. Christine Greves, is here to say ‘she listens and she doesn’t judge’, especially when it comes to helping women understand endometriosis. Addressing misconceptions may help improve care and close the women’s health gap. We’ll continue to bring awareness, investment, and scientific and commercial expertise to the healthcare ecosystem supporting the health of women. #WomensHealth #Endometriosis #EndometriosisActionMonth #EndometriosisAwareness

Felicia Bisaro, M.S. a member of the External Communications team at Organon, takes us behind the scenes at the 2025 American Academy of Dermatology (AAD) Annual Meeting. Check out some of the highlights from her day learning from industry leaders in dermatology and recognizing the announcement of Organon’s late-breaking analysis of Phase 3 data for our recently approved topical therapy for atopic dermatitis (eczema). #AAD2025 #Eczema #AtopicDermatitis #Dermatology